The randomised induction for high-risk neuroblastoma comparing COJEC and N5-MSKCC regimens: Early results from the HR-NBL1.5/SIOPEN trial.
Alberto Garaventa,Ulrike Poetschger,Dominique Valteau-Couanet,Victoria Castel,Martin Elliott,Shifra Ash,Godfrey Chi-Fung Chan,Genevieve Laureys,Maja Beck Popovic,Kim Vettenranta,Walentyna Balwierz,Henrik Schroeder,Cormac Owens,Maja Cesen,Vassilios Papadakis,Toby Trahair,Roberto Luksch,Gudrun Schleiermacher,Peter F. Ambros,Ruth Ladenstein PEDIATRIC BLOOD & CANCER（2018）
AI 理解论文
溯源树
样例
